Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Evolving Standards of Care

February 11, 2020

Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

By

Evolving Standards of Care

By Youquan Li, MD, FRCR, and Andrea Bezjak, MDCM, MSc, FRCPC Posted: February 12, 2020 Targeted agents including TKIs of EGFR, ALK, and ROS1 have significantly improved the outcomes of […]
February 11, 2020

Treating Patients with MET Alterations: A Q&A with Dr. Ravi Salgia

By

Evolving Standards of Care

Posted: February 12, 2020 Ravi Salgia, MD, PhD, is the Arthur & Rosalie Kaplan Endowed Chair in Medical Oncology and the associate director for clinical sciences at City of Hope’s […]

February 11, 2020

TRK Inhibition in TRK Fusion–Positive Lung Cancers

By

Evolving Standards of Care

By Alexander Drilon, MD Posted: February 12, 2020 The receptor tyrosine kinases TRKA/B/C are encoded by the genes NTRK1/2/3. TRK fusions are oncogenic drivers of various adult and pediatric cancers. […]
February 11, 2020

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr. Edgardo S. Santos Castillero

By

Evolving Standards of Care

Posted: February 12, 2020 Edgardo S. Santos Castillero, MD, FACP, is an IASLC Lung Cancer News Editorial Group Member and served as a co-chair on the expert panel that developed […]
February 11, 2020

CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in NSCLC

By

Evolving Standards of Care

By Neal Ready, MD, PhD Posted: February 12, 2020 Dr. Neal Ready Programmed death receptor (PD-1) checkpoint monoclonal antibody therapy has proven a major advancement in the management of advanced […]

February 11, 2020

Smoking Ban in Austria Passed After Years of Political Wrangling

By

Evolving Standards of Care

Posted: February 12, 2020 November 1, 2019—After years of political volleying and public outcry, Austria implemented a full indoor smoking ban in bars, cafes, and restaurants. With its capitol, Vienna, […]

December 10, 2019

Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC

By

Evolving Standards of Care

By Christian Rolfo, MD, PhD, MBA, Dr.h.c. Posted: December 11, 2019 IN REFERENCE TO: Phallen J, Leal A, Woodward BD, et al. Early Noninvasive Detection of Response to Targeted Therapy […]
December 10, 2019

Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies

By

Evolving Standards of Care

By Robert C. Doebele, MD, PhD Posted: December 11, 2019 Dr. Robert C. Doebele Early in the drug development of targeted therapies, specific oncogene mutations were often associated with a […]
December 10, 2019

Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy

By

Evolving Standards of Care

Improved Turnaround Times for Biopsy Results Matters More Than Type of Biopsy By Dr. Edgardo S. Santos Castillero, MD, FACP Posted: December 11, 2019 Dr. Edgardo S. Santos Castillero Regarding “Liquid Biopsy […]
December 10, 2019

Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data

By

Evolving Standards of Care

Posted: November 12, 2019 Now that data from the PACIFIC trial have been incorporated into daily practice, similar trials are validating the results or taking PACIFIC data in new directions. […]